Cisplatin for Ovarian Cancer
Ovarian cancer is a disease in which cancerous cells form in the tissues of the ovaries. Women with this type of cancer have many treatment options available to them, including:
- Surgery (see Ovarian Cancer Surgery)
- Radiation therapy (see Ovarian Cancer Radiation)
- Chemotherapy (see Ovarian Cancer Chemotherapy).
Many women receive more than one type of treatment. Cisplatin is approved for use in combination with other chemotherapy medications (in a chemotherapy "regimen") to treat metastatic ovarian cancer in women who have already received appropriate surgery and/or radiation treatments. It is also approved to be used alone as a secondary treatment after other chemotherapy regimens have failed (in women who have not yet received cisplatin in a previous regimen).
Cisplatin for Bladder Cancer
There are three types of bladder cancer that begin within the cells of the bladder lining. These cancers are named for the type of cells that become cancerous, which include:
- Transitional cell carcinoma
- Squamous cell bladder carcinoma, also known as squamous cell bladder cancer
Depending on the type and extent of bladder cancer, treatment may include:
- Surgery (see Bladder Cancer Surgery)
- Radiation therapy (see Radiation Treatment for Bladder Cancer)
- Chemotherapy (see Bladder Cancer Chemotherapy)
- Biological therapy (see Biological Treatment for Bladder Cancer)
- A combination of these methods.
Cisplatin is approved for use by itself to treat advanced transitional cell bladder cancer that can no longer be treated "locally" with radiation or surgery.